US Stock MarketDetailed Quotes

TBPH Theravance Biopharma

Watchlist
  • 9.730
  • +0.020+0.21%
Close Dec 19 16:00 ET
  • 9.730
  • 0.0000.00%
Post 20:01 ET
478.47MMarket Cap-9.45P/E (TTM)

Theravance Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-109.01%-5.2M
64.50%-4.42M
90.89%-1.02M
-1,013.28%-27M
-101.56%-854K
85.31%-2.49M
9.40%-12.44M
57.95%-11.22M
98.97%-2.43M
221.35%54.91M
Net income from continuing operations
-41.88%-12.7M
-5.65%-16.53M
47.19%-11.66M
40.54%-55.19M
40.31%-8.51M
42.32%-8.95M
31.36%-15.65M
45.14%-22.09M
64.98%-92.82M
75.34%-14.26M
Operating gains losses
-16,400.00%-163K
----
----
326.50%1.35M
-101.14%-1K
-99.97%1K
150.77%1.32M
113.74%29K
712.82%317K
--88K
Depreciation and amortization
-18.68%762K
5.95%979K
20.55%1.18M
-39.41%4.26M
-30.02%1.42M
-46.97%937K
-51.60%924K
-26.08%978K
-18.31%7.02M
58.20%2.03M
Deferred tax
--90K
---561K
---513K
--3.21M
--3.21M
--0
--0
--0
--0
----
Other non cash items
3.45%630K
13.38%644K
14.36%629K
141.27%2.35M
13.27%623K
29.30%609K
129.65%568K
-70.57%550K
152.56%974K
2,300.00%550K
Change In working capital
74.57%-342K
145.86%2.69M
79.90%4.12M
-119.69%-8.34M
-105.73%-3.41M
91.17%-1.35M
-397.82%-5.87M
157.93%2.29M
207.08%42.35M
1,154.65%59.56M
-Change in receivables
-101.90%-2.55M
110.35%365K
-37.76%2.81M
74.67%-689K
84.39%-417K
22.45%-1.26M
-1,571.09%-3.53M
152.52%4.52M
-250.86%-2.72M
-4,073.44%-2.67M
-Change in prepaid assets
135.06%657K
176.21%724K
187.18%3.99M
-155.39%-4.45M
-290.93%-3.01M
54.30%-1.87M
-136.34%-950K
-82.52%1.39M
-38.22%8.03M
-73.55%1.58M
-Change in payables and accrued expense
4,482.43%6.78M
136.52%1.14M
3.69%-3.21M
58.16%-7.09M
-227.39%-786K
102.31%148K
-488.53%-3.12M
72.12%-3.34M
58.43%-16.94M
109.65%617K
-Change in other current assets
-89.86%155K
-150.67%-226K
-102.58%-30K
81.19%-1.55M
-20.20%-4.68M
202.21%1.53M
115.73%446K
116,000.00%1.16M
-746.30%-8.23M
-11,558.82%-3.9M
-Change in other current liabilities
-1,508.40%-1.68M
-196.96%-1.24M
15.13%-1.22M
393.48%4.55M
27,041.18%4.58M
107.45%119K
-27.71%1.28M
15.99%-1.43M
-60.52%-1.55M
99.22%-17K
-Change in other working capital
----
38,760.00%1.93M
29,783.33%1.78M
-98.61%886K
-98.59%903K
0.00%-6K
97.08%-5K
33.33%-6K
647.20%63.76M
2,228.70%63.95M
Cash from discontinued investing activities
0
-761.12%-184.57M
-6,455.40%-178.97M
Operating cash flow
-109.01%-5.2M
64.50%-4.42M
90.89%-1.02M
85.56%-27M
99.31%-854K
88.77%-2.49M
15.57%-12.44M
56.96%-11.22M
10.04%-186.99M
-192.35%-124.06M
Investing cash flow
Cash flow from continuing investing activities
-82,752.38%-17.4M
-127.44%-3.03M
139.56%17.03M
-155.54%-32.7M
-101.73%-677K
99.89%-21K
47.00%11.05M
-234.84%-43.05M
-52.71%58.88M
261.80%39.16M
Net PPE purchase and sale
28.57%-15K
-107.98%-36K
87.50%-91K
-175.35%-975K
-154.51%-677K
-136.84%-21K
569.79%451K
-145.53%-728K
138.06%1.29M
40.09%-266K
Net investment purchase and sale
---17.38M
-128.27%-3M
140.45%17.12M
-157.81%-31.72M
--0
--0
39.22%10.6M
-239.55%-42.32M
-57.10%54.87M
249.90%39.43M
Net other investing changes
----
----
----
----
----
----
----
----
--2.71M
--0
Cash from discontinued investing activities
Investing cash flow
-82,752.38%-17.4M
-127.44%-3.03M
139.56%17.03M
-102.83%-32.7M
-101.73%-677K
-100.00%-21K
47.00%11.05M
-234.84%-43.05M
826.96%1.15B
261.80%39.16M
Financing cash flow
Cash flow from continuing financing activities
98.82%-372K
99.95%-44K
96.95%-1.72M
73.07%-198.93M
13.71%-30.61M
95.53%-31.4M
-57,728.57%-80.68M
-3,783.98%-56.24M
-904.07%-738.62M
-23,906.71%-35.47M
Net issuance payments of debt
----
----
----
--0
----
----
----
----
-5,786.33%-631.6M
--0
Net common stock issuance
98.82%-372K
99.48%-419K
96.95%-1.72M
-50.86%-199.55M
13.98%-30.78M
66.84%-31.4M
-23,279.25%-81.13M
-3,783.98%-56.24M
-233.46%-132.28M
-7,765.05%-35.79M
Proceeds from stock option exercised by employees
--0
----
----
-22.94%618K
-44.90%173K
-200.00%-1K
----
----
-76.89%802K
-48.01%314K
Net other financing activities
----
----
----
----
----
----
----
----
--24.46M
--0
Cash from discontinued financing activities
0
-20.19M
0
Financing cash flow
98.82%-372K
99.95%-44K
96.95%-1.72M
73.78%-198.93M
13.71%-30.61M
95.65%-31.4M
-57,728.57%-80.68M
-3,783.98%-56.24M
-926.05%-758.81M
-23,906.71%-35.47M
Net cash flow
Beginning cash position
-55.67%47.18M
-71.00%54.67M
-86.50%40.38M
229.32%299.01M
-82.71%72.52M
20.77%106.43M
98.00%188.5M
229.32%299.01M
10.32%90.8M
243.03%419.37M
Current changes in cash
32.27%-22.97M
90.87%-7.49M
112.93%14.29M
-224.21%-258.63M
73.30%-32.14M
-110.24%-33.91M
-1,059.99%-82.07M
-2,607.53%-110.51M
2,350.71%208.21M
-282.59%-120.37M
End cash Position
-66.61%24.21M
-55.67%47.18M
-71.00%54.67M
-86.50%40.38M
-86.50%40.38M
-82.71%72.52M
20.77%106.43M
98.00%188.5M
229.32%299.01M
229.32%299.01M
Free cash flow
-107.86%-5.21M
66.50%-4.45M
90.85%-1.11M
84.28%-29.49M
98.77%-1.53M
88.65%-2.51M
10.48%-13.29M
53.80%-12.16M
11.22%-187.56M
-189.94%-124.32M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -109.01%-5.2M64.50%-4.42M90.89%-1.02M-1,013.28%-27M-101.56%-854K85.31%-2.49M9.40%-12.44M57.95%-11.22M98.97%-2.43M221.35%54.91M
Net income from continuing operations -41.88%-12.7M-5.65%-16.53M47.19%-11.66M40.54%-55.19M40.31%-8.51M42.32%-8.95M31.36%-15.65M45.14%-22.09M64.98%-92.82M75.34%-14.26M
Operating gains losses -16,400.00%-163K--------326.50%1.35M-101.14%-1K-99.97%1K150.77%1.32M113.74%29K712.82%317K--88K
Depreciation and amortization -18.68%762K5.95%979K20.55%1.18M-39.41%4.26M-30.02%1.42M-46.97%937K-51.60%924K-26.08%978K-18.31%7.02M58.20%2.03M
Deferred tax --90K---561K---513K--3.21M--3.21M--0--0--0--0----
Other non cash items 3.45%630K13.38%644K14.36%629K141.27%2.35M13.27%623K29.30%609K129.65%568K-70.57%550K152.56%974K2,300.00%550K
Change In working capital 74.57%-342K145.86%2.69M79.90%4.12M-119.69%-8.34M-105.73%-3.41M91.17%-1.35M-397.82%-5.87M157.93%2.29M207.08%42.35M1,154.65%59.56M
-Change in receivables -101.90%-2.55M110.35%365K-37.76%2.81M74.67%-689K84.39%-417K22.45%-1.26M-1,571.09%-3.53M152.52%4.52M-250.86%-2.72M-4,073.44%-2.67M
-Change in prepaid assets 135.06%657K176.21%724K187.18%3.99M-155.39%-4.45M-290.93%-3.01M54.30%-1.87M-136.34%-950K-82.52%1.39M-38.22%8.03M-73.55%1.58M
-Change in payables and accrued expense 4,482.43%6.78M136.52%1.14M3.69%-3.21M58.16%-7.09M-227.39%-786K102.31%148K-488.53%-3.12M72.12%-3.34M58.43%-16.94M109.65%617K
-Change in other current assets -89.86%155K-150.67%-226K-102.58%-30K81.19%-1.55M-20.20%-4.68M202.21%1.53M115.73%446K116,000.00%1.16M-746.30%-8.23M-11,558.82%-3.9M
-Change in other current liabilities -1,508.40%-1.68M-196.96%-1.24M15.13%-1.22M393.48%4.55M27,041.18%4.58M107.45%119K-27.71%1.28M15.99%-1.43M-60.52%-1.55M99.22%-17K
-Change in other working capital ----38,760.00%1.93M29,783.33%1.78M-98.61%886K-98.59%903K0.00%-6K97.08%-5K33.33%-6K647.20%63.76M2,228.70%63.95M
Cash from discontinued investing activities 0-761.12%-184.57M-6,455.40%-178.97M
Operating cash flow -109.01%-5.2M64.50%-4.42M90.89%-1.02M85.56%-27M99.31%-854K88.77%-2.49M15.57%-12.44M56.96%-11.22M10.04%-186.99M-192.35%-124.06M
Investing cash flow
Cash flow from continuing investing activities -82,752.38%-17.4M-127.44%-3.03M139.56%17.03M-155.54%-32.7M-101.73%-677K99.89%-21K47.00%11.05M-234.84%-43.05M-52.71%58.88M261.80%39.16M
Net PPE purchase and sale 28.57%-15K-107.98%-36K87.50%-91K-175.35%-975K-154.51%-677K-136.84%-21K569.79%451K-145.53%-728K138.06%1.29M40.09%-266K
Net investment purchase and sale ---17.38M-128.27%-3M140.45%17.12M-157.81%-31.72M--0--039.22%10.6M-239.55%-42.32M-57.10%54.87M249.90%39.43M
Net other investing changes ----------------------------------2.71M--0
Cash from discontinued investing activities
Investing cash flow -82,752.38%-17.4M-127.44%-3.03M139.56%17.03M-102.83%-32.7M-101.73%-677K-100.00%-21K47.00%11.05M-234.84%-43.05M826.96%1.15B261.80%39.16M
Financing cash flow
Cash flow from continuing financing activities 98.82%-372K99.95%-44K96.95%-1.72M73.07%-198.93M13.71%-30.61M95.53%-31.4M-57,728.57%-80.68M-3,783.98%-56.24M-904.07%-738.62M-23,906.71%-35.47M
Net issuance payments of debt --------------0-----------------5,786.33%-631.6M--0
Net common stock issuance 98.82%-372K99.48%-419K96.95%-1.72M-50.86%-199.55M13.98%-30.78M66.84%-31.4M-23,279.25%-81.13M-3,783.98%-56.24M-233.46%-132.28M-7,765.05%-35.79M
Proceeds from stock option exercised by employees --0---------22.94%618K-44.90%173K-200.00%-1K---------76.89%802K-48.01%314K
Net other financing activities ----------------------------------24.46M--0
Cash from discontinued financing activities 0-20.19M0
Financing cash flow 98.82%-372K99.95%-44K96.95%-1.72M73.78%-198.93M13.71%-30.61M95.65%-31.4M-57,728.57%-80.68M-3,783.98%-56.24M-926.05%-758.81M-23,906.71%-35.47M
Net cash flow
Beginning cash position -55.67%47.18M-71.00%54.67M-86.50%40.38M229.32%299.01M-82.71%72.52M20.77%106.43M98.00%188.5M229.32%299.01M10.32%90.8M243.03%419.37M
Current changes in cash 32.27%-22.97M90.87%-7.49M112.93%14.29M-224.21%-258.63M73.30%-32.14M-110.24%-33.91M-1,059.99%-82.07M-2,607.53%-110.51M2,350.71%208.21M-282.59%-120.37M
End cash Position -66.61%24.21M-55.67%47.18M-71.00%54.67M-86.50%40.38M-86.50%40.38M-82.71%72.52M20.77%106.43M98.00%188.5M229.32%299.01M229.32%299.01M
Free cash flow -107.86%-5.21M66.50%-4.45M90.85%-1.11M84.28%-29.49M98.77%-1.53M88.65%-2.51M10.48%-13.29M53.80%-12.16M11.22%-187.56M-189.94%-124.32M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data